692
Views
25
CrossRef citations to date
0
Altmetric
Review

Advances in pharmacotherapy for primary biliary cirrhosis

, , , & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ahmad H. Ali, James H. Tabibian, Elizabeth J. Carey & Keith D. Lindor. (2016) Emerging drugs for the treatment of Primary Biliary Cholangitis. Expert Opinion on Emerging Drugs 21:1, pages 39-56.
Read now

Articles from other publishers (24)

Weici Zhang, Tihong Shao, Patrick S.C. Leung, Koichi Tsuneyama, Luke Heuer, Howard A. Young, William M. Ridgway & M. Eric Gershwin. (2022) Dual B-cell targeting therapy ameliorates autoimmune cholangitis. Journal of Autoimmunity 132, pages 102897.
Crossref
Si-Nan Lin, Ren Mao, Chenchen Qian, Dominik Bettenworth, Jie Wang, Jiannan Li, David H. Bruining, Vipul Jairath, Brian G. Feagan, Min-Hu Chen & Florian Rieder. (2022) Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases. Physiological Reviews 102:2, pages 605-652.
Crossref
Dingnan Wang, Han Yu, Yunzhou Li, Zongying Xu, Shaohua Shi, Dou Dou, Lili Sun, Zhili Zheng, Xinghua Shi, Xiulan Deng & Xianggen Zhong. (2021) iTRAQ‑based quantitative proteomics analysis of the hepatoprotective effect of melatonin on ANIT‑induced cholestasis in rats. Experimental and Therapeutic Medicine 22:3.
Crossref
Raquel T Yokoda & Eduardo A Rodriguez. (2020) Review: Pathogenesis of cholestatic liver diseases. World Journal of Hepatology 12:8, pages 423-435.
Crossref
Claudia D. Fuchs, Emina Halilbasic & Michael Trauner. 2020. The Liver. The Liver 364 377 .
Danielle Cristiane Baldo, Alessandra Dellavance, Maria Lucia Gomes Ferraz & Luis Eduardo C. Andrade. (2019) Evolving liver inflammation in biochemically normal individuals with anti-mitochondria antibodies. Autoimmunity Highlights 10:1.
Crossref
Xiang-yu Li, Sheng-hong Zhu, Fang Yang, Guo-xin Hu & Ling-jing Yuan. (2019) An ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of obeticholic acid in rat plasma and its application in preclinical pharmacokinetic studies. Journal of Chromatography B 1121, pages 82-88.
Crossref
Xaviar Michael Jones, Mariano Montiel Bertone, Verónica Gabriela Savio, Marina Laura Werner & Ingrid Strusberg. (2019) Rheumatoid arthritis associated with primary biliary cholangitis under treatment with biological drugs. Revista Argentina de Reumatología, pages 20-23.
Crossref
Adnan Malik, Ani A. Kardashian, Kais Zakharia, Christopher L. Bowlus & James H. Tabibian. (2019) Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist. Liver Research 3:2, pages 118-127.
Crossref
Fatima Bibi. (2018) Primary biliary cholangitis: an update on treatment. Gastrointestinal Nursing 16:Sup10, pages S10-S14.
Crossref
Antonella Borrelli, Patrizia Bonelli, Franca Maria Tuccillo, Ira D. Goldfine, Joseph L. Evans, Franco Maria Buonaguro & Aldo Mancini. (2018) Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches. Redox Biology 15, pages 467-479.
Crossref
Kais Zakharia, Anilga Tabibian, Keith D. Lindor & James H. Tabibian. (2018) Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver International 38:3, pages 399-411.
Crossref
Carlo Selmi & M. Eric Gershwin. (2017) Chronic Autoimmune Epithelitis in Sjögren’s Syndrome and Primary Biliary Cholangitis: A Comprehensive Review. Rheumatology and Therapy 4:2, pages 263-279.
Crossref
Michaël Duruisseaux, Nathalie Rabbe, Martine Antoine, Thibault Vieira, Virginie Poulot, Jacques Cadranel & Marie Wislez. (2017) Pro-tumoural CXCL10/CXCR3-A autocrine loop in invasive mucinous lung adenocarcinoma. ERJ Open Research 3:1, pages 00047-2016.
Crossref
Xing-Chen Yang, Masayuki Fujino, Song-Jie Cai, Shao-Wei Li, Chi Liu & Xiao-Kang Li. (2017) Genetic Polymorphisms of Cytotoxic T-Lymphocyte Antigen 4 in Primary Biliary Cholangitis: A Meta-Analysis. Journal of Immunology Research 2017, pages 1-12.
Crossref
Hirsh D Trivedi, Blanca Lizaola, Elliot B Tapper & Alan Bonder. (2017) Primary biliary cholangitis: new treatments for an old disease. Frontline Gastroenterology 8:1, pages 29-36.
Crossref
R. Abdalian, J. Heathcote & M. Ramos-Casals. 2017. The Digestive Involvement in Systemic Autoimmune Diseases. The Digestive Involvement in Systemic Autoimmune Diseases 83 101 .
Hani S. Mousa, Francesca Bernuzzi & Pietro Invernizzi. 2017. Cytokine Effector Functions in Tissues. Cytokine Effector Functions in Tissues 75 96 .
Atsushi Tanaka. 2017. Bile Acids in Gastroenterology. Bile Acids in Gastroenterology 109 119 .
Amitkumar Patel & Anil Seetharam. (2016) Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics. Journal of Clinical and Experimental Hepatology 6:4, pages 311-318.
Crossref
Ana Lleo, Zhaolian Bian, Haiyan Zhang, Qi Miao, Fang Yang, Yanshen Peng, Xiaoyu Chen, Ruqi Tang, Qixia Wang, Dekai Qiu, Jingyuan Fang, Cristina Sobacchi, Anna Villa, Luca Di Tommaso, Massimo Roncalli, M. Eric Gershwin, Xiong Ma & Pietro Invernizzi. (2016) Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis. PLOS ONE 11:9, pages e0159612.
Crossref
Hani S. Mousa, Marco Carbone, Federica Malinverno, Vincenzo Ronca, M. Eric Gershwin & Pietro Invernizzi. (2016) Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach. Autoimmunity Reviews 15:9, pages 870-876.
Crossref
Li Wang, Feng-Chun Zhang & Xuan Zhang. (2016) Therapeutic advances for primary biliary cholangitis. European Journal of Gastroenterology & Hepatology 28:6, pages 615-621.
Crossref
Jinjun Wang. (2016) Xenobiotics and loss of tolerance in primary biliary cholangitis. World Journal of Gastroenterology 22:1, pages 338.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.